CYTOKINES AND INFLAMMATORY MEDIATORS IN CYSTIC-FIBROSIS

被引：5

作者：

GUIDA, LE ^{[1
]}

FRIERI, M ^{[1
]}

机构：

[1] NASSAU CTY MED CTR,ALLERGY IMMUNOL PROGRAM,2201 HEMPSTEAD TURNPIKE,E MEADOW,NY 11554

来源：

PEDIATRIC ASTHMA ALLERGY & IMMUNOLOGY | 1994年 / 8卷 / 01期

关键词：

D O I：

10.1089/pai.1994.8.1

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Cystic fibrosis (CF), a multisystem disorder of children and adults is the most common life-threatening genetic trait in the Caucasian population. It is the major cause of severe chronic lung disease in children. Alteration of immunologic functions has been demonstrated and may play a role in the progressive pulmonary deterioration resulting in inflammation, fibrosis, and loss of function. Pulmonary inflammatory disease involves many interacting cells that release cytokines that activate several target cells of the respiratory tract. Various cytokines such as interleukin-6 (IL-6) and interleukin-8 (IL-8), platelet activating factor (PAF), and leukotriene B4 (LTB4) may be important in patients with CF who have acute and chronic purulent sputum production and exacerbation of respiratory symptoms requiring intravenous antibiotic therapy. Investigators are currently investigating cytokines and other inflammatory mediators in CF as well as in asthma. Questions remain to be answered as to the role that cytokines and inflammatory mediators play in the extent of inflammation and pulmonary damage in the cystic fibrosis population.

引用

页码：1 / 5

页数：5

共 33 条

[1]

Fink J.N., Kelly K.J., Immunologic aspects of granulomatous and interstitial lung diseases and of cystic fibrosis, JAMA, 268, pp. 2874-2881, (1992)

[2]

Moss R., Hsu Y., Lewiston N., Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and endotoxin A with mortality in cystic fibrosis, Am Rev Respiratory Dis, 133, pp. 648-652, (1986)

[3]

Carroll J.L., Taussig L.M., Pulmonary disorders., pp. 475-502, (1989)

[4]

Barnes P.J., Pathophysiology of allergic inflammation., pp. 243-266, (1993)

[5]

Barnes P.J., Chung K.F., Page C.P., Inflammatory mediators and asthma, Pharmacol Rev, 40, (1988)

[6]

Arai K., Lee F., Miyajima A., Cytokines: Coordinators of immune and inflammatory responses, Ann Rev Biochem, 59, (1990)

[7]

Hlefgott D.C., Tatter S.B., Santhanam U., Multiple forms of IFN-B2/IL-6 in serum and body fluids during acute bacterial infection, J Immunol, 142, pp. 948-953, (1989)

[8]

Fong Y., Moldawer L.L., Marano M., Endotoxemia elicits increased circulating B2-IFN/IL-6 in man, J Immunol, 142, pp. 2321-2324, (1989)

[9]

Rusconi F., Parizzi F., Garlaschi L., Interleukin-6 activity in infants and children with bacterial meningitis, Pediatr Infect Dis J, 10, pp. 117-121, (1991)

[10]

Matsuda T., Hirano T., Nagasawa S., Kishimoto T., Identification of alpha 2-macroglobulin as a carrier protein for IL-6, J Immunol, 142, pp. 148-152, (1989)

← 1 2 3 4 →